BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21426933)

  • 1. Suppression of uPA and uPAR blocks radiation-induced MCP-1 mediated recruitment of endothelial cells in meningioma.
    Nalla AK; Gogineni VR; Gupta R; Dinh DH; Rao JS
    Cell Signal; 2011 Aug; 23(8):1299-310. PubMed ID: 21426933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.
    Kargiotis O; Chetty C; Gogineni V; Gondi CS; Pulukuri SM; Kyritsis AP; Gujrati M; Klopfenstein JD; Dinh DH; Rao JS
    Int J Oncol; 2008 Nov; 33(5):937-47. PubMed ID: 18949356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo.
    Gupta R; Rao Gogineni V; Nalla AK; Chetty C; Klopfenstein JD; Tsung AJ; Mohanam S; Rao JS
    Int J Oncol; 2011 Apr; 38(4):973-83. PubMed ID: 21290090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of uPA and uPAR attenuates angiogenin mediated angiogenesis in endothelial and glioblastoma cell lines.
    Raghu H; Lakka SS; Gondi CS; Mohanam S; Dinh DH; Gujrati M; Rao JS
    PLoS One; 2010 Aug; 5(8):e12458. PubMed ID: 20805979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma.
    Rao Gogineni V; Kumar Nalla A; Gupta R; Gorantla B; Gujrati M; Dinh DH; Rao JS
    Int J Oncol; 2010 Apr; 36(4):809-16. PubMed ID: 20198323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells.
    Gorantla B; Asuthkar S; Rao JS; Patel J; Gondi CS
    Mol Cancer Res; 2011 Apr; 9(4):377-89. PubMed ID: 21389187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells.
    Raghu H; Nalla AK; Gondi CS; Gujrati M; Dinh DH; Rao JS
    Mol Oncol; 2012 Feb; 6(1):33-47. PubMed ID: 22177802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. uPAR/cathepsin B overexpression reverse angiogenesis by rescuing FAK phosphorylation in uPAR/cathepsin B down regulated meningioma.
    Gupta R; Nalla AK; Gogineni VR; Chetty C; Bhoopathi P; Klopfenstein JD; Tsung AJ; Mohanam S; Rao JS
    PLoS One; 2011 Feb; 6(2):e17123. PubMed ID: 21347260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
    Moreau M; Mourah S; Dosquet C
    Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth.
    Kondraganti S; Gondi CS; McCutcheon I; Dinh DH; Gujrati M; Rao JS; Olivero WC
    Int J Oncol; 2006 Jun; 28(6):1353-60. PubMed ID: 16685436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced hypomethylation triggers urokinase plasminogen activator transcription in meningioma cells.
    Velpula KK; Gogineni VR; Nalla AK; Dinh DH; Rao JS
    Neoplasia; 2013 Feb; 15(2):192-203. PubMed ID: 23441133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
    Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
    Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
    Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein.
    Prager GW; Mihaly J; Brunner PM; Koshelnick Y; Hoyer-Hansen G; Binder BR
    Blood; 2009 Feb; 113(6):1383-90. PubMed ID: 18948573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration.
    Ahmad A; Kong D; Sarkar SH; Wang Z; Banerjee S; Sarkar FH
    J Cell Biochem; 2009 Jun; 107(3):516-27. PubMed ID: 19330806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
    Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. uPAR and cathepsin B shRNA impedes TGF-β1-driven proliferation and invasion of meningioma cells in a XIAP-dependent pathway.
    Gogineni VR; Gupta R; Nalla AK; Velpula KK; Rao JS
    Cell Death Dis; 2012 Dec; 3(12):e439. PubMed ID: 23222509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine stimulates urokinase-type plasminogen activator receptor expression and cell invasiveness through mitogen-activated protein kinase and reactive oxygen species signaling in ECV304 endothelial cells.
    Khoi PN; Park JS; Kim NH; Jung YD
    Toxicol Appl Pharmacol; 2012 Mar; 259(2):248-56. PubMed ID: 22261521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
    Jo M; Thomas KS; Marozkina N; Amin TJ; Silva CM; Parsons SJ; Gonias SL
    J Biol Chem; 2005 Apr; 280(17):17449-57. PubMed ID: 15728176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.